Victory Square Technologies portfolio company receives approval for sale and use of Safe Covid-19 antibody for the European Union

EU and EEA countries with a combination of 446824564:

Warning:

The Company does not explicitly or implicitly make your product have the ability to remove, cure or involve the Covid-19 (or SARS-2 coronavirus) at this time.

For more information about the company, please contact: Investor Relations Contact: Alex Tzilios Email: alexandros@victorysquare. com: 778-867-0482

Media Relations Contact: Howard Blank, Email Director: Howard@victorysquare. com: 604-928-6066

ABOUT VICTORY SQUARE TECHNOLOGIES INC.

Leave a Comment

Your email address will not be published. Required fields are marked *